Paper published in a journal (Scientific congresses and symposiums)
Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: A subgroup analysis of ENGOT-OV60/GOG-3052/RAMP 201 Part A
Banerjee, Susana; Van Nieuwenhuysen, Els; Santin, Alessandro et al.
2024In Gynecologic Oncology, 190, p. 55-S56
Peer Reviewed verified by ORBi
 

Files


Full Text
Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer.pdf
Publisher postprint (144.64 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Banerjee, Susana
Van Nieuwenhuysen, Els
Santin, Alessandro
Ring, Kari
Colombo, Nicoletta
Thaker, Premal
Prendergast, Emily
Clamp, Andrew
Ray-Coquard, Isabelle
Chon, Hye Sook
Moore, Kathleen
Salinas, Erin
Rose, Peter
O'Malley, David
Oaknin, Ana
Monk, Bradley
Holloway, Robert
Newman, Gregg
Moroney, John
Van Gorp, Toon
Kalbacher, Elsa
Gennigens, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Wojtynek, Nicholas
Lustgarten, Stephanie
Grisham, Rachel
More authors (15 more) Less
Language :
English
Title :
Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: A subgroup analysis of ENGOT-OV60/GOG-3052/RAMP 201 Part A
Publication date :
November 2024
Event name :
Annual Meeting on Women’s Cancer
Event place :
San Diego, United States - California
Event date :
March 16-18, 2024
Audience :
International
Journal title :
Gynecologic Oncology
ISSN :
0090-8258
eISSN :
1095-6859
Publisher :
Elsevier BV
Special issue title :
Abstracts of the Society of Gynecologic Oncology (SGO) 2024
Volume :
190
Pages :
S55-S56
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 18 October 2024

Statistics


Number of views
4 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi